Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 5/20 | 0.67 |
| ▸ | PSMB5 | P28074 | 5/20 | 0.67 |
| ▸ | PSMB2 | P49721 | 4/20 | 0.67 |
| ▸ | LTA4H | P09960 | 12/20 | 0.65 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14084486 | 0.84 | NPC1 (0.66) | LTA4HHRH3KDM4E | |
| SCHEMBL3578646 | 0.83 | HRH3 (0.90) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL4517043 | 0.81 | PSMB1 (0.67) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL2213892 | 0.81 | PSMB1 (0.67) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL7819691 | 0.81 | LTA4H (0.90) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL8337754 | 0.81 | HRH3 (0.70) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL3578343 | 0.81 | PSMB1 (0.67) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL5606946 | 0.81 | PSMB1 (0.67) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL1986761 | 0.81 | PSMB1 (0.67) | PSMB1PSMB5PSMB2LTA4HHRH3 | |
| SCHEMBL229697 | 0.81 | LTA4H (0.90) | PSMB1PSMB5PSMB2LTA4HHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2543376-A1 | Benzotriazine inhibitors of kinases | Targegen, Inc. (US) | 2013-01-09 | — | — | EP | disclosed |
| WO-2012159981-A2 | PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS | LEK PHARMACEUTICALS D.D. (SI) | 2012-11-29 | — | — | WO | disclosed |
| EP-2524908-A1 | Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds | LEK Pharmaceuticals d.d. (SI) | 2012-11-21 | — | — | EP | disclosed |